Synagis (palivizumab) Weight Change / Vial-Size Adjustment Prior Authorization
Form and requirements for requesting a vial-size or dose increase for Synagis (palivizumab) via prior authorization, including required documentation and submission instructions for providers and pharmacies.
No material clinical or coverage changes in this revision.
Coverage Criteria
Dose/Vial Size Change Approval Criteria
Covered when ALL of the following are met
Required for review: all copies of medical records (diagnostic evaluations and recent chart notes), most recent related labs; provider must retain documentation for five years
No immediate approvals will be issued for patients who are waiting to receive an additional vial solely because of projected weight gain. Approvals for a larger vial size require documented weight changes and must be obtained prior to administration. If a patient is expected to need an additional vial (an increase of >2.5 mg over the approved vial size as noted on the form), schedule a visit to obtain a current weight and submit the Synagis Weight Change Form with the required documentation before giving the next dose.